These success, together with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the principle of focusing on ACKR3 as a unique strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Issues. (3) Besides if the patient https://assisip628jaq3.wikimillions.com/user